Kim, B. M., Thier, M. C., Oh, S., Sherwood, R., Kanellopoulou, C., Edenhofer, F., Choi, M. Y.> ;PLoS ONE. 2012
Lectures
A Phase Ib/II Study of Ibrutinib in Combination with Obinutuzumab-Gazyva As First-Line Treatment for Patients with Chronic Lymphocytic Leukemia > 65 Years Old or with ...
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Ibrutinib Reduces Obinutuzumab-Gazyva Infusion Related Reactions (IRR) in Patients with Chronic Lymphocytic Leukemia (CLL) and It Is Associated with Changes on Plasma ...
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018